Pancreatic Cancer Research

ResearcherPennsylvania State UniversityNo recent work listed

Niraj Jaysukh Gusani

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7695-5108; OpenAlex author ID A5028789154. Sources: OpenAlex.

Their work

Papers
12 (first author 2, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
24
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: none · 2020: 2 papers · 2021: 5 papers · 2022: 3 papers

Papers 12

  1. Undertreatment of Pancreatic Cancer: The Intersection of Bias, Biology, and Geography. Last author DOI 10.1016/j.soc.2021.07.006↗
  2. Do-Not-Resuscitate Orders and Outcomes for Patients with Pancreatic Cancer. Co-author DOI 10.1089/pancan.2022.0006↗
  3. Twitter Conversations About Pancreatic Cancer by Health Care Providers and the General Public: Thematic Analysis. Co-author DOI 10.2196/31388↗
  4. Pathologic upstaging in resected pancreatic adenocarcinoma: Risk factors and impact on survival. Last author DOI 10.1002/jso.26481↗
  5. Undertreatment of Pancreatic Cancer: Role of Surgical Pathology. Co-author DOI 10.1245/s10434-020-09043-y↗
  6. ASO Author Reflections: Undertreatment of Pancreatic Cancer After Resection: Don't Get Fooled by Favorable Final Pathology. First author DOI 10.1245/s10434-020-09079-0↗
  7. Adjuvant Chemotherapy After Neoadjuvant Chemotherapy for Pancreatic Cancer is Associated with Improved Survival for Patients with Low-Risk Pathology. Last author DOI 10.1245/s10434-020-09546-8↗
  8. ASO Author Reflection: Adjuvant Chemotherapy After Neoadjuvant Chemotherapy in Pancreatic Adenocarcinoma Does Not Lead to Improved Survival in All Patients. First author DOI 10.1245/s10434-021-09615-6↗
  9. Conventionally fractionated radiation therapy versus stereotactic body radiation therapy for locally advanced pancreatic cancer (CRiSP): An international syste… Co-author DOI 10.1002/cncr.32756↗
  10. Rural-Urban Disparities in Pancreatic Cancer Stage of Diagnosis: Understanding the Interaction With Medically Underserved Areas. Last author DOI 10.1111/jrh.12498↗
  11. Trends in utilization of neoadjuvant therapy and short-term outcomes in resected pancreatic cancer. Co-author DOI 10.1016/j.amjsurg.2016.08.015↗
  12. Phase I dose escalation study of capecitabine and erlotinib concurrent with radiation in locally advanced pancreatic cancer. Co-author DOI 10.1007/s00280-014-2488-7↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Elizabeth Josephine Olecki · 5 shared papers, 2021 · strength 0.96
  2. Matthew E. B. Dixon · 4 shared papers, 2021–2022 · strength 0.71
  3. Chan Shen · 4 shared papers, 2021 · strength 0.68
  4. Madeline B. Torres · 3 shared papers, 2021–2022 · strength 0.56
  5. Christopher S. Hollenbeak · 3 shared papers, 2017–2022 · strength 0.51
  6. June S. Peng · 3 shared papers, 2021 · strength 0.45
  7. Joel E. Segel · 2 shared papers, 2020–2022 · strength 0.41
  8. Qiang Hao · 1 shared paper, 2022 · strength 0.22
  9. Muhammad Shaalan Beg · 1 shared paper, 2022 · strength 0.16
  10. Udhayvir Singh Grewal · 1 shared paper, 2022 · strength 0.16
  11. Arjun Gupta · 1 shared paper, 2022 · strength 0.16
  12. Allyson J. Ocean · 1 shared paper, 2022 · strength 0.16
  13. Emil Lou · 1 shared paper, 2022 · strength 0.16
  14. Anirban Maitra · 1 shared paper, 2022 · strength 0.16
  15. Leila T. Tchelebi · 1 shared paper, 2020 · strength 0.13
  16. Nicholas George Zaorsky · 1 shared paper, 2020 · strength 0.13
  17. Daniel Michael Trifiletti · 1 shared paper, 2020 · strength 0.13
  18. Christopher H. Crane · 1 shared paper, 2020 · strength 0.13
  19. Katelin Anne Mirkin · 1 shared paper, 2017 · strength 0.10
  20. Joyce Y. Wong · 1 shared paper, 2017 · strength 0.10
  21. Chandra Prakash Belani · 1 shared paper, 2014 · strength 0.04
  22. Yixing Jiang · 1 shared paper, 2014 · strength 0.04
  23. Eric T. Kimchi · 1 shared paper, 2014 · strength 0.04
  24. Jussuf T. Kaifi · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.